PHASE I CLINICAL TRIAL on the ACTIVITY of REALBUILD®

A Phase I Clinical Trial has recently been completed at CTCA (Cancer Treatment Centers of America). The trial has shown that ReaLBuild® safely helps boost platelet count. The CTCA team is very enthusiastic about the results, and a publication is in the works. A Phase II Protocol is now being discussed.